Skip to main content
Lexston Mining Corporation logo

Lexston Mining Corporation — Investor Relations & Filings

Ticker · LEXT ISIN · CA52978C1023 LEI · 984500673A4D88AY8543 CSE Mining and quarrying
Open in API
Filings indexed 262 across all filing types
Latest filing 2023-02-24 Regulatory Filings
Country CA Canada
Listing CSE LEXT

About Lexston Mining Corporation

https://lexston.ca/

Lexston Mining Corporation is a mineral exploration company focused on the strategic acquisition, exploration, and development of mineral projects. The company aims to enhance stakeholder value through the advancement of its property portfolio. Lexston's assets include a 100% interest in the Dory property, a mineral exploration project located in British Columbia. Additionally, the corporation holds an option to acquire mineral claims situated in Mineral County, Nevada, diversifying its exploration focus across key North American regions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-02-24 English
Other.pdf
Regulatory Filings Classification · 90% confidence The document text consists solely of references to omitted pictures and contains no textual content or financial data. The total character count is only 1149, which is very short and does not include any report or announcement text. There is no indication of the document being a report itself, nor any announcement or regulatory filing text. Given the lack of content and the short length, this document cannot be classified as a substantive financial or corporate report. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-19 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed by Lexston Life Sciences Corp. It details a material change event involving an option agreement to acquire mineral property interests, including financial terms and strategic plans such as a name change and listing requirements. The document is a regulatory disclosure of a material change rather than a financial report, earnings release, or management discussion. It is a formal notification of a significant corporate event as required by securities regulations. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories. The document length is 4610 characters, which is consistent with a detailed regulatory filing rather than a brief announcement or a full financial report.
2023-01-19 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an option agreement for a mineral property acquisition and a change of business for Lexston Life Sciences Corp. It details the terms of the option agreement, payments, share issuance, and plans to change the company name and listing status. There are no financial statements, quarterly or annual results, or detailed financial analysis. The document is an announcement of a capital transaction and strategic business change, not a full financing update or capital structure change filing. It fits best under Capital/Financing Update (CAP) as it relates to a significant business transaction involving property acquisition and change of business direction.
2023-01-19 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Lexston Life Sciences Corp. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended November 30, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3004 characters), consistent with a certification letter rather than a full report.
2023-01-03 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Lexston Life Sciences Corp. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended November 30, 2022. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The content is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, without containing actual financial data or the interim report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (2989 characters), and it does not contain substantive financial statements or analysis, only the certification statement.
2023-01-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.